Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,557 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-mass-associated intraductal papillomas: is excision necessary?
Weisman PS, Sutton BJ, Siziopikou KP, Hansen N, Khan SA, Neuschler EI, Rohan SM, Franz JM, Sullivan ME. Weisman PS, et al. Among authors: sullivan me. Hum Pathol. 2014 Mar;45(3):583-8. doi: 10.1016/j.humpath.2013.10.027. Epub 2013 Nov 6. Hum Pathol. 2014. PMID: 24444467
A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.
Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT Jr, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, Kulesza P, Green D, Hansen NM, Bethke KP, Jeruss JS, Bergan R, Khan SA. Lee O, et al. Among authors: sullivan me. Clin Cancer Res. 2014 Jul 15;20(14):3672-82. doi: 10.1158/1078-0432.CCR-13-3045. Clin Cancer Res. 2014. PMID: 25028506 Free PMC article. Clinical Trial.
Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation.
Lee O, Ivancic D, Allu S, Shidfar A, Kenney K, Helenowski I, Sullivan ME, Muzzio M, Scholtens D, Chatterton RT Jr, Bethke KP, Hansen NM, Khan SA. Lee O, et al. Among authors: sullivan me. Cancer Chemother Pharmacol. 2015 Dec;76(6):1235-46. doi: 10.1007/s00280-015-2848-y. Epub 2015 Nov 11. Cancer Chemother Pharmacol. 2015. PMID: 26560487 Clinical Trial.
Syndecan-1 facilitates breast cancer metastasis to the brain.
Sayyad MR, Puchalapalli M, Vergara NG, Wangensteen SM, Moore M, Mu L, Edwards C, Anderson A, Kall S, Sullivan M, Dozmorov M, Singh J, Idowu MO, Koblinski JE. Sayyad MR, et al. Among authors: sullivan m. Breast Cancer Res Treat. 2019 Nov;178(1):35-49. doi: 10.1007/s10549-019-05347-0. Epub 2019 Jul 20. Breast Cancer Res Treat. 2019. PMID: 31327090
Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate.
Lee O, Sullivan ME, Xu Y, Rogers C, Muzzio M, Helenowski I, Shidfar A, Zeng Z, Singhal H, Jovanovic B, Hansen N, Bethke KP, Gann PH, Gradishar W, Kim JJ, Clare SE, Khan SA. Lee O, et al. Among authors: sullivan me. Clin Cancer Res. 2020 Jan 1;26(1):25-34. doi: 10.1158/1078-0432.CCR-19-0443. Epub 2019 Sep 30. Clin Cancer Res. 2020. PMID: 31570566 Clinical Trial.
4,557 results